Patents by Inventor Patrick William Mantyh

Patrick William Mantyh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
    Patent number: 8557245
    Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: October 15, 2013
    Assignees: Rinat Neuroscience Corp., Regents of The University of Minnesota
    Inventors: David L. Shelton, Patrick William Mantyh
  • METHODS FOR TREATING BONE CANCER BY ADMINISTERING A NERVE GROWTH FACTOR ANTAGONIST ANTIBODY
    Publication number: 20120315271
    Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Application
    Filed: June 13, 2012
    Publication date: December 13, 2012
    Inventors: David L. Shelton, Patrick William Mantyh
  • Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
    Patent number: 8226951
    Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: July 24, 2012
    Assignee: Pfizer Inc.
    Inventors: David L. Shelton, Patrick William Mantyh
  • METHODS FOR TREATING BONE CANCER BY ADMINISTERING A NERVE GROWTH FACTOR ANTAGONIST ANTIBODY
    Publication number: 20110243961
    Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Application
    Filed: June 6, 2011
    Publication date: October 6, 2011
    Inventors: David L. Shelton, Patrick William Mantyh
  • Methods for treating bone cancer pain by administering a nerve growth factor antagonist antibody
    Patent number: 8007800
    Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: August 30, 2011
    Assignee: Pfizer Inc.
    Inventors: David L. Shelton, Patrick William Mantyh
  • Methods for Treating Bone Cancer Pain by Administering A Nerve Growth Factor Antagonist antibody
    Publication number: 20090252744
    Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Application
    Filed: March 16, 2009
    Publication date: October 8, 2009
    Inventors: David L. Shelton, Patrick William Mantyh
  • Methods for treating bone cancer pain by administering a nerve growth factor antagonist
    Patent number: 7425329
    Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: September 16, 2008
    Assignees: Rinat Neuroscience Corp., Regents of the University of Minnesota
    Inventors: David L. Shelton, Patrick William Mantyh
  • Methods of screening for agents affecting the deposition of .beta.-amyloid peptides on amyloid plaques in human tissue
    Patent number: 5837473
    Abstract: The present invention provides a labelled .beta.-amyloid peptide or a labelled active fragment of .beta.-amyloid peptide and methods of using the labelled peptides to screen for agents which affect the deposition of the labelled peptide onto amyloid plaques in tissue samples evidencing the presence of Alzheimer's amyloidosis.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: November 17, 1998
    Assignees: President and Fellows of Harvard College, Regents of the University of Minnesota
    Inventors: John Edward Maggio, Patrick William Mantyh